Thursday, November 03, 2016 9:26:22 AM
The Company is reviewing a recent development with a limited number of commercial end-users of the Company's Intellitube product who have experienced a product failure rate of 0.57%, which is higher than the Company's historical non-Intellitube commercial product failure rate of 0.19%. Based on the Company's initial investigation it appears that product failures, which are not related to any health or safety matters, occur when the product is installed in a certain manner or with certain ballasts. Once fully investigated, the product failures will be covered through either replacement or repair under the Company's standard warranty provisions for defects in materials and workmanship for a period of ten years from the date of purchase.
Since its introduction in April 2015, the aggregate amount of the Company's Intellitube product sold as of September 30, 2016 is approximately $2.5 million. The total amount of this product sold to the end-users experiencing the notably higher failure rate is less than $600,000. No such increased product failure rates have been reported to the Company with respect to its military Intellitube product or any other commercial products.
The Company has commenced an in-depth review of this ongoing matter and is working with the end-users on a resolution, however, due to the limited time that the Company has had to review the matter, it has not yet been able to fully determine the root cause or assess the extent of the failures. Accordingly, the Company will continue investigating the product failures and assessing any probable or any estimable impact on the amount of its accrued warranty reserve and its results of operations as of September 30, 2016 prior to the filing of its Quarterly Report on Form 10-Q.
As only limited information has been reviewed to date, it is possible that the number of incidents could increase. A significant failure rate or corresponding contingency could have a material adverse impact on the Company's business, financial condition, and results of operations.
Co expects to report Q3 revs of $8.3 mln vs $8.72 mln Capital IQ Consensus Estimate
Recent EFOI News
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 05/07/2024 08:00:02 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:05:55 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 08:44:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 04:50:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 03:42:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 02:16:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 01:02:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 01:01:16 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 06:36:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 06:34:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 06:33:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 06:32:02 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/12/2023 04:15:11 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/11/2023 09:07:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 09:10:56 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM